Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study

Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study

ContextGlucocorticoid excess exhibits multiple detrimental effects by its catabolic properties. Metformin was recently suggested to protect from adverse metabolic side-effects of glucocorticoid treatment. Whether metformin is beneficial in patients with endogenous glucocorticoid excess has not been...

Full description

Bibliographic Details
Main Authors: Frederick Vogel, Leah Braun, German Rubinstein, Stephanie Zopp, Andrea Oßwald, Katharina Schilbach, Ralf Schmidmaier, Martin Bidlingmaier, Martin Reincke
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Endocrinology
Subjects:
metformin
hypercortisolism
glucocorticoids
bone density
osteoporosis
cortisol
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.765067/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.765067/full

Similar Items